Relmada Therapeutics amends exec employment pacts; salaries raised for CEO, COO, CFO, CAO

RELMADA THERAPEUTICS, INC.

CEO salary increased to $827,176 (+5% from $787,787); other terms unchanged.
COO salary increased to $524,790 (+5% from $499,800); new severance: 12 months lump sum on non-cause termination, 18 months on CIC.
CFO salary increased to $586,940 (+5% from $558,990); new severance: 12 months lump sum on non-cause termination, 18 months on CIC.
CAO salary increased to $576,440 (+5% from $548,990); new severance: 12 months lump sum on non-cause termination, 18 months on CIC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.